Nasal Endoscopy — Cost, Top Hospitals & Success Rates | MyMedicPlus

Nasal endoscopy (also called diagnostic rhinoscopy or anterior rhinoscopy with endoscope) is an examination of the nasal cavity, middle meatus, nasopharynx, and — with flexible instruments — the larynx, using a small telescope or fibreoptic camera inserted through the nostril. It is one of the most frequently performed procedures in otolaryngology (ENT) practice and provides direct, magnified, illuminated visualisation of structures that cannot be assessed by anterior rhinoscopy with a simple nasal speculum and headlight.

Endoscopic examination of the nose has become the cornerstone of modern rhinology since Karl Storz popularised the rigid Hopkins rod-lens telescope in the 1970s. Today nasal endoscopy is essential for:

• Diagnosing and monitoring chronic rhinosinusitis (CRS) with or without nasal polyps
• Planning and performing Functional Endoscopic Sinus Surgery (FESS)
• Evaluating nasopharyngeal lesions, adenoid hypertrophy, and epistaxis sources
• Assessing the vocal cords and supraglottis via a trans-nasal flexible laryngoscope

Nasal endoscopy is used to evaluate a broad range of sinonasal and nasopharyngeal conditions:

Sinusitis and Chronic Rhinosinusitis (CRS)

In CRS, endoscopy permits direct visualisation of the middle meatus — the ostiomeatal complex (OMC), ethmoid bulla, uncinate process, and frontal recess. Mucopurulent secretions, mucosal oedema, and early polypoid change in the middle meatus that would be invisible on anterior rhinoscopy are readily identified. Endoscopic findings are graded using the Lund-Kennedy Endoscopic Score (0–20 scale: polyps 0–2, discharge 0–2, oedema 0–2, scarring 0–2, crusting 0–2 for each side), which correlates with disease severity and treatment response.

Nasal Polyps

Nasal polyps arise most commonly from the ethmoid sinuses and prolapse into the middle meatus before descending to the nasal floor. Endoscopy grades polyp extent (Johansson grade 0–4 or Lund-Kennedy polyp sub-score) and distinguishes bilateral inflammatory polyps (typical of CRS with nasal polyps — CRSwNP) from unilateral lesions that may represent inverted papilloma, angiofibroma, or malignancy.

Adenoid Hypertrophy

Flexible nasal endoscopy provides a direct nasopharyngeal view of adenoid tissue in children and adults, assessing the degree of choanal obstruction and Eustachian tube cushion involvement — information essential for adenoidectomy decision-making and post-surgical assessment.

Postnasal Drip and Mucociliary Dysfunction

Pooling of mucus in the nasopharynx, muco-purulent secretions tracking along the posterior nasopharyngeal wall, and signs of mucociliary stasis (thick ropy mucus in the nasal cavities) are identified during endoscopy, guiding diagnosis of primary ciliary dyskinesia (PCD) or cystic fibrosis.

Nasopharyngeal Lesions

Flexible endoscopy permits direct biopsy of nasopharyngeal masses under local anaesthesia. Nasopharyngeal carcinoma (NPC), common in Southeast and East Asian populations, presents as a posterolateral nasopharyngeal mass or Eustachian tube fullness. Early lesions may only be visible on endoscopy with biopsy positive for Epstein-Barr virus-associated squamous cell carcinoma.

Epistaxis Evaluation

Active or recurrent epistaxis sources — including the anterior Kiesselbach plexus (Little's area), posterior lateral nasal wall, and sphenopalatine artery territory — are located endoscopically and can be treated with electrocautery or silver nitrate cauterisation at the same sitting.

Vocal Cord Examination (Flexible Naso-laryngoscopy)

Passing a flexible 3.5 mm fibreoptic scope transnasally to the oropharynx and larynx allows assessment of vocal cord mobility, glottic lesions, subglottic stenosis, and pharyngeal pathology. This is the standard method for evaluating hoarseness and dysphagia in the outpatient ENT clinic.

Nasal endoscopy is indicated in patients presenting with:

• Persistent nasal obstruction, congestion, or rhinorrhoea not responding to first-line medical therapy
• Chronic or recurrent sinusitis (symptoms for >12 weeks despite medical treatment)
• Nasal polyposis confirmed or suspected on clinical examination
• Epistaxis requiring source localisation beyond simple anterior rhinoscopy
• Suspected nasopharyngeal mass, adenoid hypertrophy (children and adults), or Eustachian tube dysfunction
• Unilateral nasal symptoms requiring exclusion of neoplasm
• Pre-operative assessment before FESS or septoplasty
• Post-operative surveillance after FESS, polypectomy, or endoscopic skull base surgery
• Hoarseness or dysphagia requiring laryngeal assessment
• Loss of smell (anosmia) where sinonasal pathology is suspected

There are very few contraindications to diagnostic nasal endoscopy. Patients on anticoagulants do not require dose adjustment for diagnostic-only examination (no biopsy). When biopsy of a vascular lesion (e.g., suspected angiofibroma) is planned, imaging and anaesthetic assessment are required first.

1. Rigid Hopkins Rod Telescopes

The rigid endoscope is the workhorse of ENT practice. Standard configurations include:

• 0° (straight-ahead): Best for anterior nasal cavity, nasal floor, anterior middle meatus, and nasal septum
• 30° (forward-oblique): Most versatile — visualises middle meatus, inferior turbinate, and nasopharynx without scope repositioning in most patients
• 45°: Useful for frontal recess, agger nasi cell, and sphenoethmoidal recess evaluation
• 70°: Allows angled views into maxillary ostium, frontal sinus floor, and lateral recesses of the sphenoid not visible with 30° or 45°

Rigid scopes provide superior image resolution and brightness versus flexible instruments. Diameter is typically 2.7 mm (paediatric) or 4 mm (adult). A video tower with HD camera, light source (LED or xenon), and recording system allows documentation and patient review.

2. Flexible Fibreoptic Nasopharyngolaryngoscope

A 3.1–4 mm flexible scope with a steerable distal tip (120–130° angulation) is passed transnasally. It navigates around the inferior turbinate to reach the nasopharynx and can be advanced to visualise the oropharynx, hypopharynx, and larynx. Image quality is lower than rigid scopes but flexible scopes access areas unreachable by rigid instruments and are better tolerated by patients with narrow nasal anatomy, septal deviation, or severe turbinate hypertrophy.

3. Preparation Protocol

For office-based (awake) nasal endoscopy:

1. Topical decongestion: 0.05% oxymetazoline or xylometazoline spray (2 puffs per nostril) applied 5–10 minutes before the procedure. This shrinks the nasal mucosa, widens the nasal passages, and reduces procedure discomfort.
2. Topical anaesthesia: 4% lidocaine or co-phenylcaine (5% lidocaine + 0.5% phenylephrine) spray or pledget applied to the nasal cavity. A dental syringe can deliver anaesthetic precisely to the middle meatus and nasopharynx.
3. Patient positioning: Seated upright in a ENT examination chair at 45° recline, head slightly extended
4. Documentation: HD photography and video recording of key anatomical landmarks and pathology for the medical record and patient education

4. Endoscopic Grading Systems

Lund-Kennedy Endoscopic Score: Standardised scoring of five endoscopic findings (polyp extent, mucopurulent discharge, mucosal oedema, scarring, crusting) on each side (maximum 20). Used in clinical trials and specialist practice to track disease over time and response to surgery or biologics.

Lund-Mackay CT Score: Parallel CT-based scoring system (0–24) assessing opacity in each sinus group and the ostiomeatal complex bilaterally. Used alongside endoscopic scoring for comprehensive CRS disease burden assessment.

5. FESS Pre-Operative Planning

Nasal endoscopy is essential before Functional Endoscopic Sinus Surgery. The endoscopist maps septal deviations, turbinate hypertrophy, anatomical variants (Haller cells, Onodi cells, paradoxical middle turbinate, concha bullosa), and the relationship between sinus pathology and critical structures (orbital lamina, skull base, optic nerve). This endoscopic-CT correlation guides the intra-operative navigation system and surgical strategy (Draf I, II, or III for frontal sinus — see Nasal Polyp Removal guide).

• Direct visualisation: Provides magnified, illuminated images of the sinonasal cavity inaccessible to routine examination, enabling accurate diagnosis and disease staging
• Outpatient/office procedure: Diagnostic nasal endoscopy requires no sedation in most patients and takes only 5–10 minutes; patients drive themselves home
• Guides medical therapy: Identifies the specific sites of disease (e.g., bilateral middle meatal polyps vs. unilateral maxillary sinus disease), directing targeted topical therapy (steroid sprays, saline irrigation) to the affected areas
• Avoids unnecessary surgery: Endoscopy can confirm adequate response to medical therapy, deferring or avoiding FESS in patients who improve; equally it identifies treatment failures early
• Biopsy access: Under endoscopic guidance, biopsies of suspicious lesions can be taken in the office setting under local anaesthesia with minimal discomfort
• Documentation: HD photographic and video records allow objective comparison at follow-up visits, aiding monitoring of polyp recurrence or post-operative mucosal healing
• Surgical planning: Pre-operative endoscopy combined with CT sinus planning reduces intra-operative complications and enables patient-specific surgical approaches

Nasal endoscopy is among the safest procedures in clinical medicine. Significant complications are rare:

Diagnostic Endoscopy (No Biopsy)

• Nosebleed (epistaxis): Minor bleeding from scope contact with nasal mucosa, typically self-limiting within minutes
• Discomfort: Transient nasal pressure or mild pain, particularly around the middle turbinate; minimised by adequate decongestion and anaesthesia
• Vasovagal reaction: Rare syncope in anxious patients; managed with supine positioning and observation
• Failure to complete examination: Severe nasal obstruction, marked septal deviation, or patient intolerance may prevent adequate visualisation; examination under general anaesthesia may be required

When Biopsy Is Performed

• Bleeding: More significant with vascular lesions; cauterisation usually achieves haemostasis
• Infection: Very rare after mucosal biopsy
• Orbital or skull base injury: Theoretical risk only for biopsies near the lamina papyracea or cribriform plate; highly unlikely with properly performed office biopsy of exophytic lesions

Limitations

• Visualisation of the frontal sinus interior, maxillary sinus lateral wall, and sphenoid sinus is limited without surgical opening
• Cannot replace CT or MRI sinus imaging for anatomical mapping before surgery
• Does not provide information about mucosal inflammation beyond the endoscope field of view

Diagnostic nasal endoscopy requires no specific recovery. Patients may experience:

• Mild nasal congestion and slight nasal numbness lasting 1–2 hours from the decongestant and anaesthetic spray
• Very minor blood-tinged nasal discharge if the mucosa was touched or biopsied — usually resolves within hours
• The ability to drive and resume normal activities immediately after a diagnostic-only examination

Following biopsy, patients should avoid nose-blowing for 24 hours and nasal decongestants beyond the day of the procedure.

Results and Next Steps

• If biopsy was taken, formal histopathology results are available in 5–10 working days
• If the endoscopy confirms CRS with nasal polyps, treatment follows the EPOS 2020 step-up algorithm (topical steroids, saline irrigation, short-course oral steroids, FESS, or biologics — see separate Nasal Polyp Removal guide)
• If a nasopharyngeal or nasal cavity mass is identified, urgent CT and MRI imaging will be arranged alongside biopsy results for MDT staging
• Post-FESS surveillance endoscopy is typically scheduled at 1 week (debridement), 4–6 weeks (healing check), 3 months, and 6–12 months thereafter

The cost of nasal endoscopy varies by country, setting, and whether surgical biopsy is performed:

Insurance coverage: In most countries, diagnostic nasal endoscopy is covered by health insurance when performed for a documented clinical indication (recurrent sinusitis, nasal obstruction, epistaxis, etc.). Cosmetic rhinoscopy for cosmetic purposes alone may not be covered.

Cost factors:

• Whether the examination is standalone or part of an ENT consultation
• Rigid vs. flexible scope (similar cost)
• Video documentation and recording fees (some hospitals charge separately)
• Histopathology fee if biopsy is taken ($150–$400 additional)

• Anterior rhinoscopy with nasal speculum and headlight: Standard assessment in primary care; visualises the anterior nasal septum, anterior turbinates, and anterior nasal floor but cannot assess the middle meatus, nasopharynx, or posterior structures. Insufficient for CRS evaluation or surgical planning.
• CT sinuses (coronal + axial): Provides anatomical mapping of all paranasal sinuses, identifies anatomical variants, and is essential before FESS. Complements but does not replace endoscopy — CT cannot distinguish mucosal oedema from mucopurulent secretions or assess active bleeding.
• MRI sinuses: Superior soft-tissue contrast, preferred for fungal sinusitis characterisation, intracranial or orbital extension, and skull base lesion evaluation. Longer scan time, higher cost than CT.
• Nasal airflow studies (rhinomanometry, acoustic rhinometry): Objective measurement of nasal resistance and geometry; useful before septoplasty to quantify functional obstruction.
• Smell testing (UPSIT, Sniffin' Sticks): Objective olfactory function assessment; nasal endoscopy is combined with smell testing to differentiate sinonasal anosmia (potentially reversible) from sensorineural olfactory loss (less reversible).
• Nasopharyngeal swab / nasal cytology: Non-endoscopic sampling methods for microbiological culture or inflammatory cell counts (eosinophil-dominant rhinitis); less sensitive than endoscopy-directed sampling.